Search

1. Increases in reimbursement for brand-name drugs in Part D

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, June 2018

Subject(s):

Drug Costs -- trends
Drug Utilization -- trends
Insurance, Health, Reimbursement
Medicare Part D -- economics
United States
United States. Department of Health and Human Services

2. Questionable billing for compounded topical drugs in Medicare Part D

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, August 2018

Subject(s):

Dermatologic Agents -- economics
Dermatologic Agents -- therapeutic use
Drug Compounding -- economics
Drug Utilization -- trends
Fraud
Insurance, Health, Reimbursement
Medicare Part D -- economics
Skin Cream -- economics
United States
United States. Department of Health and Human Services
Centers for Medicare & Medicaid Services (U.S.)

3. Trends in opioid use among social security disability insurance applicants

Author(s):

Wu, April Yanyuan, author
Brandt, Denise Hoffman, author
O'Leary, Paul, author

Publication:

Chestnut Hill, MA : Center for Retirement Research at Boston College, March 2021

Subject(s):

Analgesics, Opioid -- therapeutic use
Persons with Disabilities -- statistics & numerical data
Drug Utilization -- statistics & numerical data
Drug Utilization -- trends
Insurance, Disability -- statistics & numerical data
Insurance, Disability -- trends
Social Security -- statistics & numerical data
Social Security -- trends
United States

4. Trends in utilization management of prescription drugs in top marketplace plans

Author(s):

McSpadden, James, author

Publication:

Washington, DC : AARP Public Policy Institute, April 2022

Subject(s):

Drug Utilization -- trends
Health Insurance Exchanges -- trends
Formularies as Topic
Insurance Coverage
Prescription Drugs
United States

5. Utilization and spending trends in Medicaid outpatient prescription drugs

Author(s):

Young, Katherine, author

Publication:

[San Francisco, California] : Henry J. Kaiser Family Foundation, February 2019

Subject(s):

Drug Utilization -- economics
Drug Utilization -- trends
Health Expenditures -- trends
Medicaid -- economics
Medicaid -- trends
Prescription Drugs -- economics
United States

6. Medicare Part B drugs: trends in spending and utilization, 2008-2021

Author(s):

Nguyen, Nuguyen X., author
Olsen, T. Anders, author
Sheingold, Steven, author
De Lew, Nancy, author

Publication:

Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, June 9, 2023

Subject(s):

Cost Control
Drug Utilization -- statistics & numerical data
Drug Utilization -- trends
Health Expenditures -- statistics & numerical data
Health Expenditures -- trends
Medicare Part B -- economics
United States
United States.

7. Early changes in waivered clinicians and utilization of buprenorphine for opioid use disorder after implementation of the 2021 HHS Buprenorphine Practice Guidelines

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, December 2, 2022

Subject(s):

Buprenorphine -- therapeutic use
Drug Prescriptions -- statistics & numerical data
Drug Utilization -- statistics & numerical data
Drug Utilization -- trends
Opioid-Related Disorders -- drug therapy
Practice Guidelines as Topic
Scope of Practice
United States
United States. Department of Health and Human Services